Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Negotiating Tips for Careers in Private Practice, Academia, and Industry

Mary Beth Nierengarten  |  March 29, 2013

Negotiating a Career in Industry

Although careers in industry once were the road less traveled for many physicians, they are increasingly being chosen as alternative careers, said Gregory Dennis, MD, head of immunology, US Medical Affairs at UCB, Inc., in Smyrna, Ga.

Physicians who choose to go into industry can pursue different career paths that offer specific positions and compensation packages. A general research track includes positions in laboratory investigation (i.e., drug discovery, preclinical trials), a clinical research track includes positions necessary to conduct clinical trials (i.e., medical directors, monitors, safety assessment), and a medical affairs track includes positions necessary to pursue U.S. Food and Drug Administration review and large-scale manufacturing (i.e., late-phase research that is field based, medical information, outcomes research, and pharmacovigilance).

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Dr. Dennis focused his talk on negotiating the compensation package once an offer is made. After ensuring that the offer is in writing, he emphasized the need to carefully review the package offered to identify any areas for improvement. Among the negotiable items, he said, are base salary, sign-on bonus, initial stock option or restricted stock award, start date, transition period, car rental, and moving expenses. He emphasized that the most important piece of the offer to make a well-informed decision is an understanding of the salary particulars. He highlighted key components of salaries that can be negotiated including the type of salary (i.e., stated annually, monthly, or both), frequency of receiving a paycheck, the timing of the salary review, and different types of bonuses, including a signing bonus and performance bonus. He recommended at least asking for a sign-on bonus and said that this could be quite substantial, depending on how much the company wants a particular person.

When negotiating these items, he suggested first investigating the compensation elements for persons in similar positions and emphasized the need to refrain from making strong demands. “A little bit of diplomacy goes a long way,” he said.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Items in the contract that are less negotiable or not open to negotiation include the annual bonus target, annual stock option/restricted stock award, annual long-term incentive cash award, and vacation period.

Although one may choose one track initially, Dr. Dennis emphasized that transitioning between career paths is possible. Overall, he emphasized that compensation in industry is commensurate with one’s skill set and is competitive with other endeavors requiring similar levels of expertise.


Mary Beth Nierengarten is a freelance medical journalist based in St. Paul, Minn.

 

Page: 1 2 3 4 | Single Page
Share: 

Filed under:Uncategorized Tagged with:AcademicCareer tipsPrivate practice

Related Articles
    Prostock-studio / shutterstock.com

    Private Practice, Research, Academia? Career Tips for Rheumatology Fellows

    April 15, 2022

    As rheumatology fellows approach the end of what for many is 25th grade, it’s time to focus on what you want to do for the rest of your life. For most rheumatology fellows it will be some form of clinical practice, although enormous opportunities exist throughout the medical field for you to apply your talents….

    Is It Time to Reevaluate Your Physician Compensation Model?

    December 1, 2013

    Ongoing payment reform, healthcare consolidation forces rheumatology practices to reconsider ways doctors are paid

    Rheumatologists Saw a Gain in Compensation in 2020

    September 22, 2021

    Although patient volume temporarily declined due to the COVID-19 pandemic, rheumatologists saw a larger increase in compensation in 2020 than in 2019, according to a recent Medscape survey.

    How to Ask for a Raise

    August 13, 2017

    Whether you’re a rheumatologist or a rheumatology health professional, unless you are self-employed, the time will come when you start thinking it may be time to ask for a raise. The thought of asking for a raise likely conjures up anything but warm and fuzzy feelings, but if you do it at the right time—and…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences